NCT06995976View on ClinicalTrials.gov

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

March 1, 2026

Conditions
Malignant Tumour
Interventions
DRUG

68Ga-dPNE

Intravenous injection of 68Ga-dPNE. 68Ga-dPNE PET/CT will be used to detect tumors.

DRUG

18F-FDG

Intravenous injection of 18F-FDG.18F-FDG PET/CT will be used to detect tumors.

Trial Locations (1)

350005

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER